PROVEO
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 14 Nov 2023)
What this means for you
Registered since 16 May 2017. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (the §8 & §9 renewal is due by 16 May 2027, and its filing window is open now).
Record
- Serial number
- 86947239
- Registration number
- 5206025
- Mark type
- Word mark
- Filed
- 21 Mar 2016
- Published for opposition
- 09 Aug 2016
- Registered
- 16 May 2017
- Next maintenance filing
- §8 & §9 renewal, due by 16 May 2027 (grace period to 16 Nov 2027)
- Attorney of record
- Norm J. Rich
Goods and services
- Class 040 — Treatment of materials: Manufacture of therapeutic drugs in the nature of antibody drug conjugates
- Class 042 — Scientific and technological services: Development of therapeutic drugs in the nature of antibody drug conjugates
Owner
- CERBIOS-PHARMA SA, BARBENGO/LUGANO, CH
- IDT Biologika GmbH, Dessau-Rosslau, DE
- IDT Biologika GmbH, Dessau-Rosslau, DE
- IDT Biologika GmbH, Dessau-Rosslau, DE
Prosecution history
- 16 May 2026 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 14 Nov 2023 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 14 Nov 2023 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 14 Nov 2023 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 16 May 2023 — TEAS SECTION 8 & 15 RECEIVED
- 19 Apr 2023 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 16 May 2022 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 16 May 2017 — REGISTERED-PRINCIPAL REGISTER
- 14 Apr 2017 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 12 Apr 2017 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 01 Apr 2017 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 31 Mar 2017 — STATEMENT OF USE PROCESSING COMPLETE
- 27 Mar 2017 — USE AMENDMENT FILED
- 31 Mar 2017 — SOU EXTENSION 1 GRANTED
- 27 Mar 2017 — SOU EXTENSION 1 FILED